Search

Your search keyword '"Jensen, Dorte Møller"' showing total 152 results
Start Over Author "Jensen, Dorte Møller"
152 results on '"Jensen, Dorte Møller"'

3. Pre-analytical diagnostic differences despite high adherence to guidelines for gestational diabetes mellitus

Author

Scavenius, Cathrine, primary, Petersen, Eva Rabing Brix, additional, Jensen, Dorte Møller, additional, Ringholm, Lene, additional, Danielsen, Jakoba Sevdal, additional, Mathiesen, Elisabeth Reinhardt, additional, McIntyre, David, additional, Damm, Peter, additional, Overgaard, Martin, additional, and Clausen, Tine Dalsgaard, additional

Published
2024
Full Text
View/download PDF

5. Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women—a secondary analysis of the DALI study

Author

Dieberger, Anna M., Desoye, Gernot, Stolz, Erwin, Hill, David J., Corcoy, Rosa, Simmons, David, Harreiter, Jürgen, Kautzky-Willer, Alexandra, Dunne, Fidelma, Devlieger, Roland, Wender-Ozegowska, Ewa, Zawiejska, Agnieszka, Lapolla, Annunziata, Dalfra, Maria Grazia, Bertolotto, Alessandra, Galjaard, Sander, Adelantado, Juan M., Jensen, Dorte Møller, Andersen, Lise-Lotte, Tanvig, Mette, Damm, Peter, Mathiesen, Elisabeth Reinhardt, Snoek, Frank J., Jelsma, Judith G. M., and van Poppel, Mireille N. M.

Published
2021
Full Text
View/download PDF

6. Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial

Author

Jensen, Nanna Husted, primary, Kragelund Nielsen, Karoline, additional, Dahl-Petersen, Inger Katrine, additional, Kampmann, Ulla, additional, Damm, Peter, additional, Ovesen, Per, additional, Mathiesen, Elisabeth Reinhardt, additional, Vinter, Christina Anne, additional, Davidsen, Emma, additional, Thøgersen, Maja, additional, Timm, Anne, additional, Andersen, Lise Lotte Torvin, additional, Knorr, Sine, additional, Jensen, Dorte Møller, additional, and Maindal, Helle Terkildsen, additional

Published
2023
Full Text
View/download PDF

8. Systematically developing a family-based health promotion intervention for women with prior gestational diabetes based on evidence, theory and co-production: the Face-it study

Author

Maindal, Helle Terkildsen, Timm, Anne, Dahl-Petersen, Inger Katrine, Davidsen, Emma, Hillersdal, Line, Jensen, Nanna Husted, Thøgersen, Maja, Jensen, Dorte Møller, Ovesen, Per, Damm, Peter, Kampmann, Ulla, Vinter, Christina Anne, Mathiesen, Elisabeth Reinhardt, and Nielsen, Karoline Kragelund

Published
2021
Full Text
View/download PDF

14. Intima-Media Thickness Measurements in the Fetus and Mother During Pregnancy: A Feasibility Study

Author

Desoye, Gernot, Simmons, David, Corcoy, Rosa, Kautzky-Willer, Alexandra, van Assche, Andre, Damm, Peter, Mathiesen, Elizabeth R., Jensen, Dorte Møller, Andersen, Liselotte, Dunne, Fidelma, Lapolla, Annunziata, Di Cianni, Graziano, Snoek, Frank, van Poppel, Mireille, Wender-Ozegowska, Ewa, Zawiejska, Agnieszka, Hill, David, Rebollo, Pablo, Devlieger, Roland, Timmerman, Dirk, Galjaard, Sander, Pasman, Suzanne A., and Ameye, Lieveke

Published
2014
Full Text
View/download PDF

18. Twins in Guinea-Bissau have a ‘thin-fat’ body composition compared to singletons

Author

Wagh, Rucha, primary, Bjerregaard-Andersen, Morten, additional, Bandyopadhyay, Souvik, additional, Yajnik, Pranav, additional, Prasad, Rashmi B., additional, Otiv, Suhas, additional, Byberg, Stine, additional, Hennild, Ditte Egegaard, additional, Gomes, Gabriel Marciano, additional, Christensen, Kaare, additional, Sodemann, Morten, additional, Jensen, Dorte Møller, additional, and Yajnik, Chittaranjan S., additional

Published
2022
Full Text
View/download PDF

19. The Temporal Profile of Circulating miRNAs during Gestation in Overweight and Obese Women with or without Gestational Diabetes Mellitus

Author

Sørensen, Anja Elaine, van Poppel, Mireille N M, Desoye, Gernot, Simmons, David, Damm, Peter, Jensen, Dorte Møller, Dalgaard, Louise, Torp, Lapolla, A, The Dali Core Investigator Group, Null, and Public and occupational health

Subjects
Serum, microRNA, endocrine system diseases, Circulating biomarkers, circulating biomarkers, gestational diabetes mellitus, miR-29a-3p, serum, temporal expression profile, nutritional and metabolic diseases, Medicine (miscellaneous), MicroRNA, Gestational diabetes mellitus, General Biochemistry, Genetics and Molecular Biology, MiR-29a-3p, Temporal expression profile
Abstract

Circulating non-coding microRNAs (miRNAs) are important for placentation, but their expression profiles across gestation in pregnancies, which are complicated by gestational diabetes mellitus (GDM), have not been fully established. Investigating a single time point is insufficient, as pregnancy is dynamic, involving several processes, including placenta development, trophoblast proliferation and differentiation and oxygen sensing. Thus, the aim of this study was to compare the temporal expression of serum miRNAs in pregnant women with and without GDM. This is a nested case-control study of longitudinal data obtained from a multicentric European study (the ‘DALI’ study). All women (n = 82) were overweight/obese (BMI ≥ 29 kg/m2) and were normal glucose tolerant (NGT) at baseline (before 20 weeks of gestation). We selected women (n = 41) who were diagnosed with GDM at 24–28 weeks, according to the IADPSG/WHO2013 criteria. They were matched with 41 women who remained NGT in their pregnancy. miRNA (miR-16-5p, -29a-3p, -103-3p, -134-5p, -122-5p, -223-3p, -330-3p and miR-433-3p) were selected based on their suggested importance for placentation, and measurements were performed at baseline and at 24–28 and 35–37 weeks of gestation. Women with GDM presented with overall miRNA levels above those observed for women remaining NGT. In both groups, levels of miR-29a-3p and miR-134-5p increased consistently with progressing gestation. The change over time only differed for miR-29a-3p when comparing women with GDM with those remaining NGT (p = 0.044). Our findings indicate that among overweight/obese women who later develop GDM, miRNA levels are already elevated early in pregnancy and remain above those of women who remain NGT during their pregnancy. Maternal circulating miRNAs may provide further insight into placentation and the cross talk between the maternal and fetal compartments.

Published
2022

20. Validation of Danish registry‐cases of type 1 diabetes in women giving live birth using a clinical cohort as gold standard.

Author

Gundersen, Tina Wullum, Ebbehoj, Andreas, Knorr, Sine, Jensen, Dorte Møller, Damm, Peter, Løkkegaard, Ellen Christine Leth, Mathiesen, Elisabeth R., Thomsen, Reimar W., and Clausen, Tine Dalsgaard

Subjects
TYPE 1 diabetes, GESTATIONAL diabetes, MATERNAL age, DIAGNOSIS of diabetes
Abstract

Introduction: The aim of this study was to validate type 1 diabetes in women giving live birth in the Danish national registries against a clinical cohort of confirmed cases (the Danish Diabetes Birth Registry [DDBR] cohort). Methods: National registries including diagnosis codes, redeemed prescriptions and background data were combined. Three main algorithms were constructed to define type 1 diabetes in women giving live birth: (1) Any diabetes diagnosis registered before delivery and before age of 30, (2) a specific type 1 diabetes diagnosis registered before delivery regardless of maternal age and (3) a 'preexisting type 1 diabetes in pregnancy' diagnosis registered before delivery. In additional sub‐algorithms, we added information on anti‐diabetic medicine and gestational diabetes diagnosis. We calculated positive predictive value (PPV) and completeness using the DDBR cohort as gold standard. Since DDBR included between 75 and 93% of women with confirmed type 1 diabetes giving live birth, we used quantitative bias analysis to assess the potential impact of missing data on PPV and completeness. Results: Main algorithm 2 had the highest PPV (77.4%) and shared the highest completeness (92.4%) with main algorithm 1. Information on anti‐diabetic medicine and gestational diabetes increased PPV, on expense of completeness. All algorithms varied with PPV between 65.7 and 87.6% and completeness between 73.6 and 92.4%. The quantitative bias analysis indicated that PPV was underestimated, and completeness overestimated for all algorithms. For algorithm 2, corrected PPV was between 82.1 and 94.6% and corrected completeness between 84.7 and 91.2%. Conclusions: The Danish national registries can identify type 1 diabetes in women giving live birth with a reasonably high accuracy. The registries are a valuable source for future comparative outcome studies and may also be suitable for monitoring prevalence and incidence of type 1 diabetes in women giving live birth. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

21. The impact of anti‐hypertensive treatment on fetal growth and haemodynamics in pregnant women with pre‐existing diabetes – an explorative study

Author

Vestgaard, Marianne, primary, Al‐Saudi, Elaf, additional, Ásbjörnsdóttir, Björg, additional, Nørgaard, Lone Nikoline, additional, Pedersen, Berit Woetman, additional, Ekelund, Charlotte Kvist, additional, Ringholm, Lene, additional, Andersen, Lise Lotte Torvin, additional, Jensen, Dorte Møller, additional, Tabor, Ann, additional, Damm, Peter, additional, and Mathiesen, Elisabeth R., additional

Published
2021
Full Text
View/download PDF

24. Systematically developing a family-based health promotion intervention for women with prior gestational diabetes based on evidence, theory and co-production: the Face-it study

Author

Maindal, Helle Terkildsen, primary, Timm, Anne, additional, Dahl-Petersen, Inger Katrine, additional, Davidsen, Emma, additional, Hillersdal, Line, additional, Jensen, Nanna Husted, additional, Thøgersen, Maja, additional, Jensen, Dorte Møller, additional, Ovesen, Per, additional, Damm, Peter, additional, Kampmann, Ulla, additional, Vinter, Christina Anne, additional, Mathiesen, Elisabeth Reinhardt, additional, and Nielsen, Karoline Kragelund, additional

Published
2021
Full Text
View/download PDF

26. Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women—a secondary analysis of the DALI study

Author

Dieberger, Anna M., primary, Desoye, Gernot, additional, Stolz, Erwin, additional, Hill, David J., additional, Corcoy, Rosa, additional, Simmons, David, additional, Harreiter, Jürgen, additional, Kautzky-Willer, Alexandra, additional, Dunne, Fidelma, additional, Devlieger, Roland, additional, Wender-Ozegowska, Ewa, additional, Zawiejska, Agnieszka, additional, Lapolla, Annunziata, additional, Dalfra, Maria Grazia, additional, Bertolotto, Alessandra, additional, Galjaard, Sander, additional, Adelantado, Juan M., additional, Jensen, Dorte Møller, additional, Andersen, Lise-Lotte, additional, Tanvig, Mette, additional, Damm, Peter, additional, Mathiesen, Elisabeth Reinhardt, additional, Snoek, Frank J., additional, Jelsma, Judith G. M., additional, and van Poppel, Mireille N. M., additional

Published
2020
Full Text
View/download PDF

33. Protocol for a randomised controlled trial of a co-produced, complex, health promotion intervention for women with prior gestational diabetes and their families: the Face-it study.

Author

Nielsen, Karoline Kragelund, Dahl-Petersen, Inger Katrine, Jensen, Dorte Møller, Ovesen, Per, Damm, Peter, Jensen, Nanna Husted, Thøgersen, Maja, Timm, Anne, Hillersdal, Line, Kampmann, Ulla, Vinter, Christina Anne, Mathiesen, Elisabeth Reinhardt, Maindal, Helle Terkildsen, and Face-it Study Group

Subjects
RISK perception, GESTATIONAL diabetes, HEALTH promotion, HEALTH literacy, TYPE 2 diabetes, SOCIAL perception, DISEASE complications
Abstract

Background: Gestational diabetes mellitus (GDM) is associated with an increased risk of future diabetes in both mother, father and offspring. More knowledge is needed about how to effectively reduce the risk of diabetes through sustained behavioural interventions in these families. The Face-it intervention is a complex health promotion intervention embedded in multi-level supportive environments. The aim of the intervention is to reduce type 2 diabetes risk and increase quality of life among families in the first year following a GDM-affected pregnancy by promoting physical activity, healthy dietary behaviours and breastfeeding through a focus on social support, motivation, self-efficacy, risk perception and health literacy.Methods: This national multicentre study is a two-arm randomised controlled trial including 460 women with GDM in a ratio of 2 (intervention):1 (usual care). The Face-it intervention consists of three main components: 1) additional visits from municipal health visitors, 2) digital health coaching tailored to family needs and 3) a structured cross-sectoral communication system in the health care system. The intervention runs from 3 to 12 months after delivery. The primary outcome is maternal body mass index at 12 months after delivery as a proxy for diabetes risk. The women will be examined at baseline and at follow-up, and this examination will include blood tests, oral glucose tolerance test (OGTT), anthropometrics, blood pressure, self-reported diet and physical activity, breastfeeding, quality of life, health literacy, physical and mental health status, risk perception and social support. Aside from those data collected for OGTT and breastfeeding and offspring parameters, the same data will be collected for partners. Data on offspring anthropometry will also be collected. Information on pregnancy- and birth-related outcomes will be derived from the medical records of the woman and child.Discussion: This randomised controlled trial seeks to demonstrate whether the Face-it intervention, addressing the individual, family and health care system levels, is superior to usual care in reducing diabetes risk for mothers and their families. Coupled with a process evaluation and an economic analysis, the study will provide evidence for policymakers and health services about health promotion among families affected by GDM and the potential for reducing risk of type 2 diabetes and associated conditions.Trial Registration: ClinicalTrials.gov NCT03997773. Registered June 25, 2019 - Retrospectively registered. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

35. Diabetes in pregnancy outcomes: a systematic review and proposed codification of definitions

Author

Feig, Denice S, Corcoy, Rosa, Jensen, Dorte Møller, Kauzky-Willer, Alexandra, Nolan, Christopher J, Oats, Jeremy J N, Sacks, David A, Caimari, Francisca, and McIntyre, H David

Subjects
Diabetes Complications, Diabetes, Gestational, Diabetes mellitus, Pregnancy, Terminology as Topic, Pregnancy in diabetic patients, Disease Progression, Pregnancy in Diabetics, Infant, Newborn, Pregnancy Outcome, Humans, Female, Gestational diabetes
Abstract

Rising rates of diabetes in pregnancy have led to an escalation in research in this area. As in any area of clinical research, definitions of outcomes vary from study to study, making it difficult to compare research findings and draw conclusions. Our aim was to compile and create a repository of definitions, which could then be used universally. A systematic review of the literature was performed on published and ongoing randomized controlled trials in the area of diabetes in pregnancy between 01 Jan 2000 and 01 Jun 2012. Other sources included the World Health Organization and Academic Society Statements. The advice of experts was sought when appropriate definitions were lacking. Among the published randomized controlled trials on diabetes and pregnancy, 171 abstracts were retrieved, 64 full texts were reviewed and 53 were included. Among the ongoing randomized controlled trials published in ClinicalTrials.gov, 90 protocols were retrieved and 25 were finally included. The definitions from these were assembled and the final maternal definitions and foetal definitions were agreed upon by consensus. It is our hope that the definitions we have provided (i) will be widely used in the reporting of future studies in the area of diabetes in pregnancy, that they will (ii) facilitate future systematic reviews and formal meta analyses and (iii) ultimately improve outcomes for mothers and babies.

Published
2015

39. Overvægtige gravide og komplikationer i relation til graviditet og fødsel

Author

Vinter, Christina Anne, Honnens Tanvig, Mette, Damm, Peter, Naver, Klara Vinsand, Andreasen, Kirsten Riis, Andersen, Lise Lotte Torvin, Liest, Sara, Lunde, Søren, Jensen, Dorte Møller, and Renault, Kristina Martha

Subjects
reproductive and urinary physiology, female genital diseases and pregnancy complications
Abstract

One third of the pregnant Danish women are overweight or obese. Maternal obesity is an independent risk factor for adverse maternal and foetal outcomes including infertility, miscarriage, congenital malformations, preeclampsia, gestational diabetes, complicated deliveries, caesarean section, macrosomia and childhood obesity. This article reviews the effect of maternal obesity on obstetric and neonatal outcomes and provides recommendations for management of obesity in pregnancy.

Published
2012

44. Pregnancy and perinatal outcomes according to surgery to conception interval and gestational weight gain in women with previous gastric bypass.

Author

Stentebjerg, Louise Laage, Andersen, Lise Lotte Torvin, Renault, Kristina, Støving, René Klinkby, and Jensen, Dorte Møller

Subjects
WEIGHT gain, PREGNANT women, GASTRIC bypass, PREGNANCY, BIRTH weight, CESAREAN section, OBESITY complications, GESTATIONAL age, EVALUATION of medical care, MEDICAL protocols, PREGNANCY complications, TIME, LOGISTIC regression analysis, BODY mass index, RETROSPECTIVE studies
Abstract

Objective: To compare perinatal and pregnancy outcomes including adherence to the Institute of Medicine's (IOM) recommendations for gestational weight gain (GWG) in pregnant women with conception <18 months (early group) compared to ≥18 months following gastric bypass (late group).Methods: Retrospective cohort study comprising 71 women with gastric bypass and a singleton pregnancy presenting at Odense University Hospital, November 2007-October 2013. Data were extracted from medical records and laboratory systems. The primary outcomes were timing of pregnancy and adherence to the IOM's recommendations for GWG. Secondary outcomes were birthweight, preterm delivery, cesarean section (CS), iron deficiency and post partum hemorrhage (PPH).Results: Forty-three (61%) women conceived less than 18 months after gastric bypass surgery. Women in the late group had a significantly higher risk of requiring CS or receiving intravenous iron supplementation compared to the early group (57% versus 30%, p = 0.03 and 29% versus 7%, p = 0.02, respectively). Early conception was not significantly associated with insufficient GWG, preterm delivery or birthweight. Among 54 women with information on GWG, only 13 (24%) had an appropriate GWG.Conclusion: The majority of pregnant women with gastric bypass did not fulfill guidelines for GWG; however, this study could not support the recommendation to postpone pregnancy. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

45. Increasing incidence of diabetes after gestational diabetes:a long-term follow-up in a Danish population

Author

Lauenborg, Jeannet, Hansen, Torben, Jensen, Dorte Møller, Vestergaard, Henrik Bech, Mølsted-Pedersen, Lars, Hornnes, Peter, Locht, Henning, Pedersen, Oluf Borbye, and Damm, Peter

Subjects
Adult, Time Factors, endocrine system diseases, Denmark, Incidence, Infant, Newborn, nutritional and metabolic diseases, Gestational Age, Glucose Tolerance Test, Middle Aged, Glucagon, Body Mass Index, Cohort Studies, Diabetes, Gestational, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Pregnancy, Diabetes Mellitus, Humans, Female, Follow-Up Studies
Abstract

To study the incidence of diabetes among women with previous diet-treated gestational diabetes mellitus (GDM) in the light of the general increasing incidence of overweight and diabetes and to identify risk factors for the development of diabetes.

Published
2004

46. Intima-Media Thickness Measurements in the Fetus and Mother During Pregnancy: A Feasibility Study

Author

Galjaard, Sander, primary, Pasman, Suzanne A., additional, Ameye, Lieveke, additional, Timmerman, Dirk, additional, Devlieger, Roland, additional, Desoye, Gernot, additional, Simmons, David, additional, Corcoy, Rosa, additional, Kautzky-Willer, Alexandra, additional, van Assche, Andre, additional, Damm, Peter, additional, Mathiesen, Elizabeth R., additional, Jensen, Dorte Møller, additional, Andersen, Liselotte, additional, Dunne, Fidelma, additional, Lapolla, Annunziata, additional, Di Cianni, Graziano, additional, Snoek, Frank, additional, van Poppel, Mireille, additional, Wender-Ozegowska, Ewa, additional, Zawiejska, Agnieszka, additional, Hill, David, additional, and Rebollo, Pablo, additional

Published
2014
Full Text
View/download PDF

48. Proposed diagnostic thresholds for gestational diabetes mellitus according to a 75-g oral glucose tolerance test:Maternal and perinatal outcomes in 3260 Danish women

Author

Jensen, Dorte Møller, Damm, P, Sørensen, B, Mølsted-Pedersen, L, Westergaard, J G, Korsholm, L, Ovesen, P, and Beck-Nielsen, H

Subjects
Adult, Cohort Studies, Diabetes, Gestational, Pregnancy, Risk Factors, Denmark, Pregnancy Outcome, Humans, Female, Glucose Tolerance Test, Sensitivity and Specificity
Abstract

AIMS: To study if established diagnostic threshold values for gestational diabetes based on a 75-g, 2-h oral glucose tolerance test can be supported by maternal and perinatal outcomes.METHODS: Historical cohort study of 3260 pregnant women examined for gestational diabetes on the basis of risk indicators. Information on oral glucose tolerance test results and clinical outcomes were collected from medical records.RESULTS: There was an increased risk of delivering a macrosomic infant in women with 2-h capillary blood glucose of 7.8-8.9 mmol/l compared with women with 2-h glucose < 7.8 mmol/l. Despite treatment, 2-h glucose of 9.0-11.0 mmol/l and > or = 11.1 mmol/l were both associated with increased rates of macrosomia, spontaneous preterm delivery, hypertensive complications, and neonatal hypoglycaemia. Adverse outcomes tended to be more frequent in women with 2-h glucose > or = 11.1 mmol/l than in women with 2-h glucose of 9.0-11.0 mmol/l.CONCLUSIONS: The risk for several maternal and perinatal complications increased with the diagnostic threshold for 2-h glucose. Large-scale blinded studies are needed to clarify the question of a clinically meaningful diagnosis of gestational diabetes mellitus. Until these results are available, a 2-h threshold level of 9.0 mmol/l after a 75-g oral glucose tolerance test seems acceptable.

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results